Price
Financials
Consolidated, Rs crore| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 276 | 308 | 377 | 467 | 270 | 402 | 386 |
| Expenses | 273 | 268 | 335 | 374 | 257 | 366 | 343 |
| Operating Profit | 3 | 40 | 42 | 93 | 13 | 36 | 43 |
| OPM % | 1.0% | 13% | 11% | 20% | 4.9% | 9% | 11% |
| Other Income | 1 | 8 | 3 | 1 | -3 | 9 | 8 |
| Interest | 8 | 8 | 8 | 9 | 10 | 10 | 7 |
| Depreciation | 6 | 7 | 7 | 7 | 8 | 8 | 9 |
| Profit before tax | -11 | 32 | 30 | 78 | -8 | 27 | 35 |
| Tax % | -43% | 32% | 24% | 25% | -22% | 28% | 25% |
| Net Profit | -6 | 22 | 23 | 58 | -6 | 20 | 26 |
| EPS in Rs | -1.49 | 5.81 | 6.02 | 15.20 | -1.38 | 4.40 | 5.67 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 903 | 1,077 | 1,191 | 1,203 | 1,152 | 1,287 | 1,517 | 1,526 |
| Expenses | 832 | 949 | 1,062 | 1,125 | 1,028 | 1,137 | 1,332 | 1,341 |
| Operating Profit | 72 | 129 | 129 | 79 | 124 | 150 | 185 | 185 |
| OPM % | 8% | 12% | 11% | 7% | 11% | 12% | 12% | 12% |
| Other Income | 4 | 11 | 14 | 6 | 12 | 14 | 9 | 15 |
| Interest | 25 | 18 | 24 | 37 | 34 | 31 | 37 | 35 |
| Depreciation | 18 | 18 | 20 | 21 | 20 | 23 | 30 | 32 |
| Profit before tax | 34 | 103 | 100 | 27 | 82 | 110 | 127 | 133 |
| Tax % | 36% | 34% | 25% | 21% | 26% | 26% | 26% | |
| Net Profit | 21 | 68 | 76 | 22 | 61 | 82 | 95 | 99 |
| EPS in Rs | 72.32 | 229.88 | 255.77 | 77.84 | 235.61 | 21.38 | 21.05 | 23.89 |
| Dividend Payout % | 10% | 4% | 4% | 3% | 4% | 4% | 5% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 7% | 8% | 18% | ||
| Compounded Profit Growth | % | 8% | 67% | 21% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 15% | 18% | 17% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 27 | 26 | 39 | 47 |
| Reserves | 302 | 366 | 439 | 336 | 344 | 411 | 725 |
| Borrowings | 169 | 139 | 320 | 324 | 235 | 297 | 262 |
| Other Liabilities | 242 | 383 | 466 | 444 | 374 | 491 | 513 |
| Total Liabilities | 742 | 918 | 1,255 | 1,132 | 980 | 1,238 | 1,547 |
| Fixed Assets | 159 | 161 | 166 | 169 | 177 | 214 | 228 |
| CWIP | 7 | 9 | 11 | 16 | 51 | 50 | 67 |
| Investments | 2 | 0 | 2 | 3 | 8 | 12 | 16 |
| Other Assets | 573 | 747 | 1,076 | 945 | 745 | 961 | 1,236 |
| Total Assets | 742 | 918 | 1,255 | 1,132 | 980 | 1,238 | 1,547 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 80 | 114 | -44 | 104 | 207 | 38 | 59 |
| Cash from Investing Activity | -24 | -19 | -42 | -47 | -19 | -80 | -74 |
| Cash from Financing Activity | -59 | -50 | 157 | -159 | -178 | 30 | 152 |
| Net Cash Flow | -3 | 45 | 71 | -102 | 10 | -12 | 137 |
| Free Cash Flow | 64 | 91 | -93 | 70 | 179 | -34 | -17 |
| CFO/OP | 132% | 112% | -23% | 169% | 180% | 45% | 56% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 113 | 99 | 125 | 126 | 103 | 112 | 133 |
| Inventory Days | 119 | 153 | 182 | 155 | 111 | 189 | 146 |
| Days Payable | 113 | 162 | 165 | 156 | 114 | 176 | 158 |
| Cash Conversion Cycle | 120 | 90 | 142 | 125 | 99 | 126 | 121 |
| Working Capital Days | 54 | 51 | 72 | 56 | 39 | 50 | 68 |
| ROCE % | 23% | 18% | 8% | 17% | 21% | 19% |
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Promoters | 71.72% | 71.72% |
| FIIs | 11.54% | 9.19% |
| DIIs | 2.96% | 0.37% |
| Public | 13.78% | 18.73% |
| No. of Shareholders | 8,444 | 7,876 |
Fundamentals
Market Cap₹ 2,198 Cr.
Current Price₹ 469
Stock P/E21.0
Book Value₹ 166
ROCE18.9 %
ROE16.5 %
Dividend Yield0.21 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)18%
Compounded Profit Growth (TTM)21%
Consolidated figures.
Valuation
Market capRs 2,127 Cr
Enterprise valueRs 2,408 Cr
P/E (TTM)21.35x
Price to book5.85x
Price to sales1.49x
EV / EBITDA12.71x
EV / EBIT14.85x
EV / sales1.69x
Price to cash flow20.55x
Earnings yield4.68%
Dividend yield0.03%
Profitability
Operating margin (excl. other income)6.55%
Operating margin (incl. other income)7.09%
EBITDA margin13.27%
Pre-tax margin9.01%
Net profit margin6.98%
Net margin, latest quarter12.69%
ROE5.14%
ROCE8.70%
ROA1.79%
ROE, 3-year average13.74%
ROCE, 3-year average16.97%
ROA, 3-year average5.63%
ROIC (approx.)19.85%
Tax rate21.06%
Other income / net worth1.79%
Growth
Sales growth (latest year)1.01%
Profit growth (latest year)-71.63%
Sales CAGR, 3 years10.02%
Profit CAGR, 3 years0.11%
Sales growth QoQ23.95%
Profit growth QoQ152.30%
Per share
EPS (TTM)Rs 21.28
EPS (latest year)Rs 77.84
EPS (latest quarter)Rs 12.66
EPS, 3-year averageRs 187.83
Book value per shareRs 77.64
Sales per shareRs 305.08
Cash flow per shareRs 22.11
Free cash flow per shareRs -3.63
Dividend per share (latest year)Rs 2.00
Dividend per share, 3-year averageRs 7.67
Dividends
Dividend payout2.57%
Dividend payout, 3-year average3.74%
Efficiency
Asset turnover1.06x
Fixed asset turnover7.11x
Inventory turnover2.77x
Inventory days132 days
Debtor days126 days
Debtors turnover2.90x
Creditor days158 days
Cash conversion cycle121 days
Working capital days68 days
Leverage
Total debtRs 324 Cr
Cash and bankRs 43 Cr
Net debtRs 281 Cr
Debt to equity0.89x
Net debt / EBITDA1.48x
Interest coverage4.84x
Current ratio (filing 2026-03-31)1.61x
Quick ratio (filing 2026-03-31)1.13x
Trade payables (filing 2026-03-31)Rs 386 Cr
Owners' fund to total sources32.11%
Debt to assets28.64%
Cash flow
Cash from Operating Activity (latest year)Rs 104 Cr
Cash from Investing Activity (latest year)Rs -47 Cr
Cash from Financing Activity (latest year)Rs -159 Cr
Net Cash Flow (latest year)Rs -102 Cr
Free cash flow (latest year)Rs -17 Cr
FCFE (approx.: FCF + change in debt)Rs -13 Cr
Cash from ops / profit, 5 years1.08x
Sales to cash flow11.62x
Statement figures
Net sales (TTM)Rs 1,428 Cr
Net sales (latest year)Rs 1,203 Cr
Sales (latest quarter)Rs 467 Cr
Operating profit excl. other income (latest year)Rs 79 Cr
Operating profit (latest quarter)Rs 93 Cr
Other income (TTM)Rs 12 Cr
EBITDA (TTM)Rs 189 Cr
PBDT (TTM)Rs 156 Cr
Profit before tax (TTM)Rs 129 Cr
Tax (latest year)Rs 6 Cr
Net profit (TTM)Rs 100 Cr
Net profit (latest year)Rs 21 Cr
Net profit (latest quarter)Rs 59 Cr
Depreciation (TTM)Rs 27 Cr
Depreciation (latest quarter)Rs 7 Cr
Interest (TTM)Rs 34 Cr
Cost of goods sold (latest year)Rs 972 Cr
Total expenditure (latest year)Rs 1,125 Cr
Total income (latest year)Rs 1,210 Cr
Share capitalRs 27 Cr
ReservesRs 336 Cr
Shareholders' fundsRs 363 Cr
Total assetsRs 1,132 Cr
Net blockRs 169 Cr
Capital work in progressRs 16 Cr
InvestmentsRs 3 Cr
ReceivablesRs 415 Cr
InventoryRs 351 Cr
Other liabilitiesRs 444 Cr
Shares outstanding (crore)4.68
Ownership
Promoter holding71.72%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | GSPCROP | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -7.4% | -2.8% | -4.6 pts |
| 1 month | -26.9% | -6.8% | -20.1 pts |
| 3 months | +12.5% | -7.6% | +20.1 pts |
| 6 months | +34.5% | +0.4% | +34.1 pts |
Red flags
F-score 5 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹386 Cr +2.4% vs Jun 2025.
Net profit ₹26 Cr +13.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| UPL Ltd | 45,402 | 23.0 | 10.1 % |
| P I Industries Ltd | 34,725 | 32.2 | 15.0 % |
| Sumitomo Chemical India Ltd | 21,521 | 37.7 | 23.5 % |
| Bayer CropScience Ltd | 16,191 | 22.1 | 29.1 % |
| Sharda Cropchem Ltd | 6,509 | 10.4 | 30.2 % |
| Dhanuka Agritech Ltd | 4,148 | 15.5 | 23.8 % |
| Rallis India Ltd | 3,882 | 17.0 | 14.1 % |
| Bhagiradha Chemicals & Industries Ltd | 3,128 | 114 | 4.53 % |
| NACL Industries Ltd | 3,101 | 120 | 8.13 % |
| Insecticides India Ltd | 1,706 | 13.6 | 15.8 % |
| Bharat Rasayan Ltd | 1,673 | 12.0 | 16.1 % |
| Astec Lifesciences Ltd | 1,552 | -5.44 % | |
| India Pesticides Ltd | 1,533 | 14.2 | 16.6 % |
| Meghmani Organics Ltd | 1,458 | 22.7 | 6.71 % |
| Punjab Chemicals & Crop Protection Ltd | 1,283 | 19.2 | 18.6 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-09-11 | Dividend - Re 1 Per Share |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
High low price variation greater than 75perc in previous 3 months
Quick answers
What is the market cap of GSP Crop Science Ltd?
GSP Crop Science Ltd (GSPCROP) has a market capitalisation of Rs 2,198 Cr. at the 2026-10-01 close.
What is the P/E ratio of GSP Crop Science Ltd?
GSP Crop Science Ltd trades at a P/E of 21.0 on trailing twelve-month profit, at the 2026-10-01 close.
What were GSP Crop Science Ltd's latest quarterly results?
In the Jun 2026 quarter, GSP Crop Science Ltd sales was Rs 386 Cr (+2.4% vs Jun 2025) and net profit was Rs 26 Cr.
What is the 52-week high and low of GSP Crop Science Ltd?
The 52-week high is Rs 667.95 and the 52-week low is Rs 328.00.